Skip to main content
OpenTrials
Completed

NCT Number: NCT03667105

Evaluation of Two Types of Matrix (Mucograft® and Mucoderm®) Associated With Coronally Advanced Flap

The aim of this study is to evaluate clinically the results of two types of matrix (Geistlich Mucograft® and Mucoderm®) associated with CAF technique for the treatment of gingival recessions.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Laís Fernanda Ferreira Ferraz

São José dos Campos, São Paulo, 12245905, Brazil

About this study

This is a prospective, parallel and controlled clinical trial. The population that will be evaluated in the study will be selected at Institute of Science and Technology (ICT), São José dos Campos, College of Dentistry.

Seventy-five patients presenting gingival recession will be divided in 3 groups:

  • Group CAF + XDM (25): Periodontal surgery for root coverage through coronally advanced flap technique plus xenogenous dermal matrix graft Mucoderm®.
  • Group CAF + MC (25): Periodontal surgery for root coverage through coronally advanced flap technique plus xenogenous collagen matrix graft Mucograft®.
  • Group CAF (25): Periodontal surgery for root coverage through coronally advanced flap alone.

All surgeries will be performed by a single operator (MPS) at the dental clinic of ICT. Two horizontal incisions will be made at right angles to the adjacent interdental papillae, without interfering with gingival margins of neighboring teeth. Two oblique vertical incisions will be extended beyond the mucogingival junction and a trapezoidal mucoperiosteal flap will be raised up to the mucogingival junction. After, a split-thickness flap will be extended apically, releasing the tension and favoring coronal positioning of the flap. The exposed root surface will be scaled and planed. After the root planning procedures are performed, the epithelial layer from incised papillae will be removed to expose the connective tissue. After this, the group in which the participant is inserted will be revealed to the surgeon. The grafts will be used according to the producers' instructions. In the CAF + MD group, the matrix will be placed without previous hydration with saline solution, whereas in the CAF + XDM group the matrix will be hydrated with sterile saline for 10 minutes. In both grafts groups, the matrix will be cut into the desired dimensions to cover the entire surface of the root and around the bone, being positioned at the CEJ level. The matrix will be sutured independently of the flap, with the porous surface in contact with the tooth and bone, while the smooth surface will be facing the flap. Then, the flap will be coronally positioned and sutured to completely cover the graft. After the surgical procedure, the patients will receive the appropriate postoperative recommendations and sutures will be removed after 10 to 14 days of the surgical procedure.

Clinical parameters will be assessed at baseline and 3 and 6 months postoperatively.

Quantitative data were recorded as mean ± standard deviation (SD), and normality was tested using Shapiro-Wilk tests. The probing depth (PD), relative gingival recession (RGR), clinical attachment level (CAL), keratinized tissue thickness (KTT), keratinized tissue width (KTW), aesthetic (A), postoperative discomfort (PD), dentin hypersensitivity (DH) and tissue edema (TE) values will be examined variance test. Patients' esthetics and discomfort measures using a visual analog scale (VAS) will be analyzed by T-tests. The frequency of complete root coverage will be compared using χ2 tests. Intergroup root coverage esthetic score (RES) comparisons will be performed with a T-test.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients presenting Miller class I or II gingival recession in the maxillary canines or premolars;
  • Teeth included in the study should present pulp vitality and no associated with carious or cervical lesion;
  • Patients presenting no signs of active periodontal disease and full-mouth plaque and bleeding score ≤ 20%;
  • Probing depth ˂ 3 mm in the included and adjacent teeth, presenting no signs of bleeding or attachment loss;
  • Patients older than 18 years old;
  • Patients who agreed to participate and signed an informed consent form.

Exclusion criteria

  • Patients with systemic problems (cardiovascular, blood dyscrasias, immunodeficiency, and diabetes, among others) that will contraindicate the surgical procedure;
  • Patients taking medications known to interfere with the wound healing process or that contraindicate the surgical procedure;
  • pregnant or lactating women;
  • Smokers;
  • Patients who underwent periodontal surgery in the area of interest;
  • Patients with orthodontic therapy in progress.

Treatment and study plan

CAF

Procedure

Periodontal surgical technique to treat gingival recessions.

Other names: Periodontal plastic surgery

MC

Other

Xenogenous graft placed in the surgical site.

Other names: Xenogenous collagen matrix graft (Mucograft®)

XDM

Other

Xenogenous dermal collagen graft placed in the surgical site.

Other names: Xenogenous dermal collagen matrix graft (Mucoderm®)

Primary outcomes

  1. Percentage of defect coverage

    Time frame: 6 months

    Percentage mean (%) of root surface covered by the surgical treatment, measured through a periodontal probe.

Secondary outcomes

  1. Root coverage esthetic score

    Time frame: 6 months

    This analysis will be performed through the Root Coverage Aesthetics Scale (RES, cairo et al., 2009), by 3 blinded and independent examiners at the 6-month post-operative assessment. The RES method uses a "score" that evaluates the following parameters:

    • Level of the gingival margin (0=failure of the root covering, 3=partial covering, 6=total covering);
    • Marginal tissue contour (0=irregular contour, 1=normal contour);
    • Soft tissue texture (0=presence of scar or keloid; 1=absence of scar or keloid);
    • Mucogingival junction alignment: (0=mucogingival line not aligned with the line of the neighboring teeth; 1=mucogingival line aligned with the line of the neighboring teeth);
    • Gingival color (0=color of gingival tissue different from the neighboring tissues; 1=color of treated gingival tissue equal to neighboring tissues).

    According to the sum of scores received, the teeth will be considered: aesthetic (score=10), partially aesthetic (score= 1-9) or without aesthetic (score=0).

  2. Evaluation of root dentine hypersensitivity with the air blow test

    Time frame: 6 months

    The assessment of root sensitivity will be performed by applying a blow of air in the region of the surgical procedure for 5 seconds. The patient should mark on a Visual Analogue Scale (VAS) the perceived sensitivity. On this visual scale (range 0-10), the extreme "0" represents "none discomfort or sensitivity" and the extreme "10" represents "extreme discomfort or sensitivity". Thus, higher values represent a worse outcome.

  3. Evaluation of patient recovery through the report of discomfort and postoperative pain

    Time frame: 7 days

    At the end of the first post-operative week (7 days) the patients will receive a questionnaire with questions about the occurrence of discomfort and postoperative pain, that will be evaluated by means of a Visual Analog Scale (VAS). On this visual scale (range 0-10), the extreme "0" represents "none discomfort or pain" and the extreme "10" represents "extreme discomfort or pain". Thus, higher values represent a worse outcome. In addition, patients were asked to report the number of analgesics tablets ingested during that week.

  4. Aesthetic evaluation according to patient through Visual Analog Scale (EVA)

    Time frame: 6 months

    Aesthetic evaluation according to the opinion of the patient will be performed in the baseline and at the 6-month post-operative assessment. Looking at a mirror, the patient will visualize the area of gingival surgery and mark in a Visual Analogue Scale (EVA) the aesthetic of the element in question. On this visual scale, the left extreme represents "very ugly" and the right extreme represents "very beautiful". Thus, closer values of "very beautiful" will represent better outcomes.

Sponsors and collaborators

Lead sponsor

Universidade Estadual Paulista Júlio de Mesquita Filho

Other

Registry information

Official study title

Evaluation of Two Types of Matrix (Mucograft® and Mucoderm®) Associated With Coronally Advanced Flap for the Treatment of Single Gingival Recessions: Randomized Clinical Trial

Important dates

Study start
2018
Primary completion
2019
Study completion
2020
First posted
Sep 12, 2018
Registry last updated
May 1, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.